Department of Surgery, Arnot Health Medical Center, Elmira, NY, USA.
Trauma and Acute Care Surgery, 209639Penn Medicine Lancaster General Health, Lancaster, PA, USA.
Am Surg. 2022 Aug;88(8):1754-1759. doi: 10.1177/00031348221083935. Epub 2022 Mar 25.
In trauma patients using warfarin, current guidelines recommend computed tomography of the brain (CTH), 24-hour observation, and repeat CTH to monitor for stability. Despite growing evidence of uncommon delayed hemorrhage, this remains standard practice even in mild traumatic brain injury without intracranial hemorrhage (ICH). Our study sought to determine the incidence and outcomes of delayed ICH (DICH) in trauma patients on supra-therapeutic warfarin without initial ICH.
A retrospective, single institutional study was performed of all adult trauma patients (>18 years old) who presented on prehospital warfarin with an international normalized ratio (INR) >3 and initial CTH that did not demonstrate ICH. Each of these patients underwent subsequent CTH within 24 hours and any DICH was identified. Those who demonstrated DICH were further examined to identify potential risk factors and outcomes such as need for further imaging or surgical intervention. Analyses were performed using Fisher's exact tests and Student's t-tests.
225 patients were identified from January 2015 to April 2021 that met inclusion criteria. Of those identified, only 3 (1.33%) were found to develop any DICH on routine repeat CTH. Identified characteristics did not reach statistical significance due to the low number of DICH. None of the patients with DICH went on to require intervention.
In patients with identified traumatic injury on supra-therapeutic warfarin, an initial CTH without identified ICH alone is an adequate survey. DICH in these patients is uncommon and routine reimaging within 24 hours is unlikely to change clinical management in patients with intact neurologic status.
在使用华法林的创伤患者中,目前的指南建议进行脑部计算机断层扫描(CTH)、24 小时观察和重复 CTH 以监测稳定性。尽管有越来越多的证据表明罕见的迟发性出血,但即使在没有颅内出血(ICH)的轻度创伤性脑损伤中,这仍然是标准做法。我们的研究旨在确定在没有初始 ICH 的情况下,使用超治疗剂量华法林的创伤患者中迟发性 ICH(DICH)的发生率和结局。
对所有成年创伤患者(>18 岁)进行回顾性单机构研究,这些患者在院前使用华法林,国际标准化比值(INR)>3,初始 CTH 未显示 ICH。这些患者中的每一位都在 24 小时内接受了随后的 CTH,任何 DICH 都被确定。那些表现出 DICH 的患者进一步检查以确定潜在的风险因素和结局,如是否需要进一步的影像学或手术干预。使用 Fisher 确切检验和学生 t 检验进行分析。
从 2015 年 1 月至 2021 年 4 月,确定了 225 名符合纳入标准的患者。在确定的患者中,只有 3 名(1.33%)在常规重复 CTH 上发现任何 DICH。由于 DICH 的数量较少,因此未达到统计学意义的特征。没有 DICH 的患者需要干预。
在明确诊断创伤性损伤的华法林超治疗剂量患者中,初始 CTH 无明确 ICH 是足够的检查。这些患者的 DICH 并不常见,在神经功能完整的患者中,24 小时内常规重新成像不太可能改变临床管理。